Silberstein joins GentiBio as CFO
Plus new CTO, CDO at Finch; and updates from Generation Bio, Atea and more
GentiBio Inc. hired Chuck Silberstein as CFO. Silberstein was previously CFO and head of business development at Applied Therapeutics Inc. (NASDAQ:APLT) and SVP of corporate business development at Allergan Inc. GentiBio is developing engineered regulatory T cell therapies for immunology and raised a $157 million series A last year.
Microbiome therapeutics company Finch Therapeutics Group Inc. (NASDAQ:FNCH) hired Bryan Gillis as CTO, Alka Batycky as chief development officer (CDO), and Howard Franklin as SVP of late-stage development and gastrointestinal therapeutic area lead. Gillis was VP of manufacturing and supply at Rubius Therapeutics Inc. (NASDAQ:RUBY), Batycky was CDO at Ohana Biosciences and Franklin was CMO at Salix Pharmaceuticals Inc. ...